Subscribe To
Bridgebio pharma announces new england journal of medicine publication of positive encaleret proof-of-concept phase 2b results in patients with autosomal dominant hypocalcemia type 1 (adh1)
– In our study, encaleret restored physiologic mineral homeostasis in 13 participants with ADH1, specifically correcting hypocalcemia and reducing h...
October 10, 2023, 11:30 am
Lyra therapeutics: hold for phase 3 topline
Lyra Therapeutics has two product candidates in clinical trials for Chronic rhinosinusitis (CRS) patients. Both candidates, LYR-210 and LYR-220, show ...
October 10, 2023, 10:56 am
Ocugen mucosal vaccine candidate ocu500 selected by nih/niaid project nextgen for inclusion in clinical trials
NIAID is conducting early phase clinical trials on select next generation vaccine candidates with the i...
October 10, 2023, 10:30 am
Annexon announces clinical and regulatory progress for anx005 pivotal program in guillain-barré syndrome (gbs)
ANX005 Granted Orphan Drug Designation by the European Medicines Agency for the Treatment of GBS Target Enrollment Achieved in ...
October 10, 2023, 10:30 am
Merck immunotherapy shows further promise in lung cancer
Merck & Co confirmed that its cancer drug Keytruda has successfully met the second of its two primary targets in a ...
October 10, 2023, 9:11 am
Filament health says health canada authorizes phase 2 clinical trial studying botanical psilocybin for opioid use disorder
Filament Health Corp (OTCQB:FLHLF, NEO:FH) told investors that Health Canada has approved a phase 2 cli...
October 10, 2023, 8:21 am
Spc nickel corp completes phase 1 and 2 drill programs at west graham
SPC Nickel Corp (TSX-V:SPC, OTC:SPCNF) has completed its phase 1 and 2 drill programs at the West Graha...
October 10, 2023, 7:47 am
Ebay's first chief ai officer is building ai tools to change how people shop online, saying the ai 'paradigm shift' will happen in three phases
E-commerce companies eBay and Shopify are both building tools that enable online sellers to use AI. eBay chief AI officer Nitzan Mekel-Bobrov said he ...
October 10, 2023, 5:00 am
Oxford cannabinoid technologies shares jumo 6% on successful completion of phase i study
Shares in Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP, OTC:OCTHF) rose 6% following the successful completion of the ...
October 10, 2023, 3:56 am
Immunic shares soar 48% after-hours buoyed by interim ms data
Shares in Immunic Therapeutics Inc. soared 48% in after-hours trading following the release of encouraging interim data from its ...
October 10, 2023, 3:50 am
Oxford cannabinoid readies for next stage as it safely navigates phase i stduy
Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP, OTC:OCTHF) hailed as a 'major milestone' the successful completion of dosing for all cohorts...
October 10, 2023, 2:22 am
Lifevantage “all in” global convention 2023 showcases next phases of lv360, consultant training, product reveals, new sales incentives, and more
Convention hosted in San Antonio, TX, October 5-7, attended by over 2,000 Independent Consultants from around the world SALT LAKE CITY, Oct. 09, 2023 ...
October 9, 2023, 8:05 pm
Harpoon therapeutics to present interim tolerability and response data from phase 1/2 clinical trial of t cell engager hpn328 at esmo congress 2023
SOUTH SAN FRANCISCO, Calif., Oct. 09, 2023 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (Nasdaq: HARP), a clinical-stage immunotherapy company deve...
October 9, 2023, 4:17 pm
Akero therapeutics to present results from phase 2b symmetry study investigating efruxifermin in patients with compensated cirrhosis due to nash
Investor webcast on Tuesday, October 10 at 8:00 a.m. ET to present clinical data Investor webcast on Tuesday, October 10 at 8:00 a.m. ET to present cl...
October 9, 2023, 4:05 pm
Kineta to present preclinical data on vista blocking kva12123 at immuno us 2023
SEATTLE, Oct. 09, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immun...
October 9, 2023, 12:10 pm
Forexlive european fx news wrap: dollar firms, equities pinned down on middle east turmoil
Headlines:Reminder: It is a US bond market holiday todayStocks continue to be pinned lower so far todayECB's de Guindos: Inflation to fall in the comi...
October 9, 2023, 12:05 pm
Easyjet share price sits and waits for october 12
The easyJet (LON: EZJ) share price has been in a consolidation phase in the past few weeks as traders w...
October 9, 2023, 11:04 am
Eur/usd: euro falls on fresh risk aversion
EURUSD came under pressure from fresh risk aversion as violent clashes in the Middle East boosted uncertainty, prompting investors into safety. The pa...
October 9, 2023, 10:52 am
Sutro biopharma: luvelta data for endometrial cancer treatment approaching
Sutro Biopharma is advancing its lead candidate, luvelta, for the treatment of various types of cancer, with a focus on ovarian and endometrial cancer...
October 9, 2023, 9:48 am
Ecb's kazaks: the phase of rapid rate hikes is already behind us
Can currently count on the fact that we may pauseSo, any future rate hikes would be relatively smallSome token remarks there by Kazaks. The fact of th...
October 9, 2023, 6:53 am